Nerbio Medical Software Platforms, Inc.

Nerbio Medical Software Platforms manufactures and delivers the iTOF®, the world's first and only FDA-cleared, wireless, app-controlled quantitative train-of-four (TOF) neuromuscular monitoring device. The iTOF connects to smartphones and tablets to provide real-time, quantitative neuromuscular assessments in perioperative settings without requiring bulky standalone equipment or significant capital investment. The platform integrates advanced AI assistance to help clinicians accurately guide neuromuscular blocking agent dosing and determine optimal post-operative recovery timing. Delivered as a Medical Device as a Service subscription model, iTOF operates at minimal daily cost (approximately $1/day) with full replacement warranty and no disposable costs. Clinical data demonstrates 10% improvement in operating room throughput, 15–30% reduction in neuromuscular blocking agent use, and significant reduction in post-operative residual blockade complications. The device is portable, battery-operated, hands-free, and compatible with both iOS and Android platforms. Nerbio is building a comprehensive platform of mobile, AI-powered monitoring solutions for perioperative and critical care environments.